Early Clinical Trial Unit
Welcome to our page of the Early Clinical Trial Unit.
We are dedicated to advancing the development of new drugs and treatment methods for hematological and oncological conditions. We understand that early clinical trials are a crucial step in this process, which is why our focus is on conducting phase I clinical trials to evaluate drug tolerability.
You are here:
What is Phase-I?
Phase I trials offer patients the opportunity to be among the first to try new and innovative treatments. These trials are the earliest stage of testing for new medicines and procedures, so there is very little or no experience with the tested medicines or procedures on patients.
Because of this, patients who participate in these trials are carefully selected and treated with special care. However, they also have the opportunity to be among the first to try new and innovative treatments.
At the Charité hospital, the hematological-oncological Early Clinical Trial Unit is part of the Comprehensive Cancer Center, which includes all clinics working in oncology and hematology. This means that patients have access to the latest advancements in cancer treatment.
Team Early Clinical Trial Unit
How to find us
Phase I trails are conducted at the Charité on the Benjamin Franklin Campus either as inpatient trials in a separate area on the oncology department or as outpatient trials in the oncology portal outpatient department.
In addition to the treatment areas, the Early Clinical Trial Unit has a laboratory for sample processing and storage as well as areas for documentation.